PRESENTATION

Q1 2020 — Presentation

Q1 2020PDF · 40 pages2.4 MB
DOW
1Q 2020 RESULTS
April 30, 2020

-- 1 of 40 --

2
AGENDA
Dow’s Response to COVID-19
Quarterly Highlights
Points of Distinction:
Dow’s Differentiated Strengths
Financial Overview & Near-Term Outlook

-- 2 of 40 --

 	Net Sales of $9.8B – in-line with guidance
 	Modest volume decline YoY, down 1% (excluding H&E)
 	Constrained economic activity & COVID-19 containment efforts in Asia
 	Demand growth in food packaging, health and hygiene & cleaning end-
markets
 	Generated $1.2B of cash flow from operating activities – continuing
operations, up $193MM YoY
 	Significantly improved cash flow conversion (Op. EBITDA-to-CFFO) YoY
to 79% from 55%
 	Executed €2.25B Eurobond issuance – extended debt maturity profile
and reduced financing costs
 	Recovered $259MM in tax withholdings from the Canadian tax
authority related to the 2019 judgment against Nova Chemicals
 	Returned $643MM to shareholders: $518MM in dividends and
$125MM in share repurchases
3
1Q 2020 HIGHLIGHTS
>$800MM
Free cash flow
generation
79%
Op. EBITDA-to-CFFO
cash conversion
~$12B
Available cash &
committed liquidity
$643MM
Returns to
shareholders

-- 3 of 40 --

4
#DowStrong

-- 4 of 40 --

5
• Our first priority is the safety of our employees –
in response to the COVID-19 pandemic we enabled ~2/3 of
employees to work remotely and enhanced health safety
measures for all our colleagues still operating our plants to
support essential end-markets.
• Our crisis management structure is engaged –
ensuring business continuity through safe operations to
reliably meet customer demand.
• We are staying close to customers and suppliers –
working to anticipate supply needs and demand
challenges; dynamically making operational adjustments to
meet evolving market demands.
Ensuring Safety &
Business Continuity

-- 5 of 40 --

6
• We are committed to putting our assets to work to
help combat the COVID-19 pandemic – ramped up raw
material production for critically needed products, such as:
• 	Disinfectants & sanitizers
• 	Personal protective equipment (PPE) & medical supplies
• 	Food supply and packaging
• We’ve adapted 5 Dow sites to produce hand sanitizer
– Michigan, West Virginia, Belgium, Germany & Brazil
• We are delivering innovative solutions in collaboration
with our customers and industry partners like a
simplified face shield design, to address the urgent PPE
needs among healthcare professionals
Playing a Critical Role

-- 6 of 40 --

7
• We have committed $3MM to aid COVID-19 relief
efforts worldwide – $2MM for immediate support of
impacts caused by COVID-19 and $1MM to build
community resilience in the recovery phase.
• We are donating hand sanitizer produced at our sites –
to local health systems, government agencies and used at
our manufacturing sites to help protect employees on the
frontlines.
• We are providing ways for employees to stay engaged
and contribute – through virtual volunteering and
financial donations to front-line organizations.
Supporting Global
Community

-- 7 of 40 --

8
1Q20 OPERATING S EGMENT PERFORMANCE
• Sales declined 10% vs. pro forma results in SQLY; volume was flat as growth in
consumer-staple packaging applications was offset by lower ethylene sales from
increased internal derivative consumption
• Operating EBIT was down, driven by PE margin compression
• Packaging and Specialty Plastics reported volume growth of 1% as gains in APAC and
LAA more than offset declines in U.S. & Canada and EMEAI
• Hydrocarbons & Energy reported decreases in volume, price and currency
Packaging & Specialty Plastics
Industrial Intermediates & Infrastructure
Performance Materials & Coatings
• Sales declined 13% vs. pro forma results in SQLY; volume was down 3% as growth in
Industrial Solutions was more than offset by declines in Polyurethanes & Con. Chem.
• Operating EBIT was down, driven by margin compression and lower equity earnings
• Polyurethanes & Construction Chemicals reported a volume contraction due to soft
demand in furniture and bedding, automotive, appliance and deicing applications
• Industrial Solutions reported volume growth driven by strong demand in cleaning
applications
• Sales declined 11% vs. pro forma results in SQLY; volume was down 3% as growth in
coatings end-markets was offset by a decline in silicones applications
• Operating EBIT was down, driven by margin compression in siloxanes
• Consumer Solutions volume contracted as demand growth in upstream siloxanes and
home and personal care in the U.S. & Canada was offset by declines in other regions
• Coatings & Performance Monomers saw volume growth driven by demand for
industrial coatings (road markings and wood applications) and monomers

-- 8 of 40 --

 	Announcing today a comprehensive set of near-term actions for remainder of 2020
 Targeting a YoY cash release from working capital of at least ~$500MM
 Trimming expenses by ~$350MM
 Further reducing CapEx target to $1.25B, down $750MM YoY
 	Temporarily idling or cutting rates to balance production with demand
 Plastics: Idling 5 polyethylene/elastomers facilities in the Americas for at least 1 month
 PU: Running reduced global PO and MDI rates until industrial demand improves
 Silicones: Running reduced siloxanes rates globally; maintaining full flexibility in finished
silicone applications
9
PROACTIVE M EASURES TO ADDRESS C URRENT M ARKET CONDITIONS
Taking actions to fortify our financial position and preserve our long-term advantage

-- 9 of 40 --

 Final logistics service agreement has been signed, the final
substantive step to Project Completion
 Debt re-profiling discussions with lenders are underway
 Sadara and JV owners are making progress in executing
longer-term structural operating improvements
 Dow’s total expected loans to Sadara in 2020 remains at
up to ~$500MM
10
SADARA U PDATE

-- 10 of 40 --

1Q 2020 F INANCIAL HIGHLIGHTS
11
YoY Operating EPS Reconciliation Key Drivers in the Quarter
• 	Demand growth in food packaging, health
and hygiene, and cleaning applications on
consumer purchasing trends in response to
COVID-19
• 	Strong cash flow from operations
• 	Removed >$30MM in stranded costs
• 	Unfavorable YoY tax rate offset by lower
interest expense, D&A and share count
• 	Weaker demand in automotive, appliance
and select home & personal care
applications, especially in China due to
COVID-19
• 	Rapid compression of oil/gas spread, driven
by steep drop in global oil prices
• 	Lower JV equity earnings, driven primarily by
margin compression in MEG and
polyethylene
Financial Summary
($ millions, unless otherwise noted)
1Q20
As Reported
1Q19
Pro Forma
YoY
B/(W)
4Q19
As Reported
QoQ
B/(W)
Net Sales 	$9,770 	$11,016 	$(1,246) 	$10,204 	$(434)
Equity Losses 	$(89) 	$(14) 	$(75) 	$(21) 	$(68)
Income (loss) from Continuing Ops., Net of Tax 	$258 	$208 	$50 	$(2,310) 	$2,568
Operating EBIT
Op. EBIT Margin (%)
Adj. Op. EBIT Margin (ex. Eq. Earnings (%))
$843
8.6%
9.5%
$1,143
10.4%
10.5%
$(300)
(180) bps
(100) Bps
$1,033
10.1%
10.3%
$(190)
(150) bps
(80) Bps
EPS – diluted 	$0.32 	$0.24 	$0.08 	$(3.14) 	$(3.46)
Operating EPS – diluted 	$0.59 	$0.98 	$(0.39) 	$0.78 	$(0.19)
Cash Provided by Op. Activities – Cont. Ops.
Op. EBITDA to CFFO (Cash Flow Conversion, %)
$1,236
79%
$1,043
55%
$193 	$1,920
110%
$(684)
$0.98
$0.59
1Q19 	Stranded Cost
Removal
COVID-19 & Margin
Compression
Equity Losses 	3rd Party Supplier
Issues in Spain
1Q20

-- 11 of 40 --

12
FINANCIAL STRENGTH , E XTENSIVE L IQUIDITY, PROACTIVE LIABILITY MANAGEMENT
Reduced refinancing risk and lower interest expense while preserving financial strength and flexibility
Extensive Liquidity & De-Risked Debt Profile
Debt Towers
Robust Financial Position and Cash Generation
 	Cash and committed liquidity covers >2/3rds of total
debt; 100% of committed liquidity is untapped
 	No substantive debt maturities until 2H23
 	Recovered $259MM in tax withholdings from the
Canadian tax authority related to the 2019 judgment
against Nova Chemicals
 	Achieved ~85% Op. EBITDA-to-CFFO cash conversion on
a TTM basis
 	Executed €2.25B Eurobond issuance at wtd avg coupon
of ~1%; proceeds used to repay debt and extend debt
maturities in a debt-neutral way
 	Annual net interest expense run-rate down additional
$100MM vs 2019 and $200MM vs 2018
Cash & Cash
Equivalents ($3.6B)
End-1Q20 Liquidity
Revolver ($5B)	Other Committed
Liquidity ($3.42B)
~$12B Available Cash & Liquidity
Term Loan
$0.4 	$0.5 $0.2 $0.4
$1.25
2020* 	2021 	2022 	2023
*Does not include $800MM of uncommitted lines drawn and held on deposit

-- 12 of 40 --

13
FY 2020 M ODELING GUIDANCE & L ATEST U PDATES [ POSITIVE / NEGATIVE ]
Operational EBIT Drivers vs. FY19
Equity Earnings Equity losses YoY on compressed oil-gas spread, COVID-19
demand softness ~($200MM headwind YoY)
Pension Expense 	Pension Expense (~$125MM headwind YoY)
Corporate 	Op. EBIT of ~$(325)MM and Op. EBITDA of ~$(280)MM
Currency 	Headwind YoY, driven by Euro & LAA currencies
Fixed Cost Reductions $350MM tailwind YoY; 20% realized in 2Q, 40% realized in 3Q,
40% realized in 4Q
Turnaround Costs 	~$100MM tailwind YoY, back-half loaded
Stranded Cost 	~$140MM in savings realized YoY
Cash Flow Considerations in 2020
Capex 	~$1.25B ($750MM lower YoY)
Sadara 	~$500MM cash outflow (flat YoY)
Pension
Contributions ~$250MM - $300MM cash outflow (approximately flat YoY)
Integration,
Separation,
Severance
Spending
~$350MM cash outflow, primarily spent in 1H20 (down
~$900MM YoY)
Working Capital
Release ~$500MM tailwind YoY
Tax Payment $259MM received in 1Q20 from the Canadian Government
for prior Nova legal settlement withholding tax
Dividends from
Equity Companies ~$250MM (down ~$800MM YoY)
Other Income Statement Considerations
Net Interest Expense 	~$800MM
D&A 	~$2.9B
Net Income Attrib.
to Non-Controlling Int. ~$75MM (reduction to reported Net Income)
Share Count 	~740MM (buybacks currently suspended)
Op. Tax Rate 	30% – 35%
Assumes economies begin to reopen in Q2, and build through 2H

-- 13 of 40 --

14
2Q20 M ODELING GUIDANCE
Net Sales 	$7.5B – $8.5B 	Depreciation & Amortization 	~$735MM
Operational Tax Rate 	30% – 35% 	Net Interest Expense (Net of Int. Income) 	~$200MM
Net Income Attrib. to Non-Controlling Int. 	~$20MM 	Share Count 	~740MM
Top-Line Ranges (2Q20 vs. 1Q20) 	Base Case Op. EBIT Drivers (2Q20 vs. 1Q20)
Volume % ∆ QoQ 	Sales % ∆ QoQ
Low 	High 	Low 	High
Packaging &
Specialty
Plastics
-10% 	-0% 	-20% 	-10%
 Robust demand in food, health and hygiene applications, offset by demand softness with lower economic activity
 PE margin pressure on compressed oil-gas ratio impacting mainly our Americas business, partially mitigated by
our Naphtha based sales in other regions
 Lower equity earnings (~$25MM headwind)
 Expense controls (~$25MM net tailwind) and beginnings of China rebound
Industrial
Intermediates
& Infrastructure
-20% 	-10% 	-30% 	-20%
 Strong demand for solvents and surfactants for sanitization applications, offset by global demand softness,
particularly in PU chain – discretionary consumer durables (autos, construction, furniture/bedding)
 MDI spreads remain at trough conditions globally
 Lower equity earnings on weak MEG pricing (~$50MM headwind)
 Expense controls (~$10MM net tailwind) and beginnings of China rebound
Performance
Materials &
Coatings
-15% 	-5% 	-20% 	-10%
 Global demand softness, notably in industrial applications and coatings
 Siloxanes and acrylic monomer prices remain challenged on loose global fundamentals
 Expense controls (~$15MM net tailwind) and beginnings of China rebound
Corporate 	Sales of $60 - $70MM 	 Op. EBIT of $(70) - $(80)MM and Op. EBITDA of $(60) - $(70)MM
Assumes economies begin to reopen in Q2, and build through 2H

-- 14 of 40 --

15
DOW ’ S POINTS OF DISTINCTION
Superior Product Mix
Unmatched Feedstock Flexibility 	Geographic Breadth
Serving Critical End-Markets

-- 15 of 40 --

POINTS OF D ISTINCTION : FEEDSTOCK , PRODUCT M IX & M ARGIN RESILIENCE
Source: Dow Investor Day Nov 2018
NORTH AMERICA
EUROPE
Unmatched Feedstock Flexibility
22
19
21
14
Op. EBITDA/lb. POLYOLEFINS CAPACITY (cpp)1
Higher, More Resilient Margins
(1) Segment EBITDA based on FY19 reported figures including equity income from affiliates/JVs (Borealis based on 2Q19 TTM
with FY18 D&A). Capacity based on latest company reported nameplate for PE and PP (2019 for Dow, 2019 Data book source for
Lyondell) including share of JVs, or ICIS reported capacity for 2019 including share of JVs if not available (Borealis).
Investor Day 2018 	Full Year 2019
Superior Product Mix
Op. EBITDA/Lb.
BALANCED PORTFOLIO
Functional
Polymers3
Polyethylene
OP. EBITDA PER POUND
Differentiated
asset
capabilities
allow Dow to
meet diverse
customer
demands
Functional
Polymers deliver
>50% higher Op.
EBITDA/lb. of
ethylene from
same process
technologies (3)
(2) Borealis Polyolefins EBITDA adjusted for equity earnings from JVs.
20% 	40% 	60% 	80%
Ethane
Propane
Naphtha
0% 	100%
Dow
Industry
0% 	100%
Dow
Industry
Naphtha
And
Other (2)
LPG
20% 	40% 	60% 	80%
Functional
Polymers
20%
LDPE
15%
LLDPE
43%
HDPE
22%
kbbl/day
kbbl/day
16

-- 16 of 40 --

17
POINTS OF DISTINCTION: S OLUTIONS FOR C RITICAL E ND -M ARKETS
Cleaning 	Food Packaging 	Health & Hygiene
Pharmaceuticals 	Personal Care 	Infrastructure

-- 17 of 40 --

18
POINTS OF DISTINCTION: GEOGRAPHIC DIVERSITY & BREADTH
North America
manufacturing sites
in 2 countries	35
Latin America
manufacturing sites in
4 countries	18
Asia Pacific
manufacturing
sites in 10
countries
19
Europe, Middle East, Africa & India
manufacturing sites in
15 countries	37
INDUSTRIAL INTERMEDIATES
& INFRASTRUCTURE
PERFORMANCE MATERIALS
& COATINGS
PACKAGING & SPECIALTY PLASTICS
NA
EMEAI
APAC
LAA
NA
EMEAI
APAC
LAA
NA
EMEAI
APAC
LAA
1Results for the first quarter of 2019 and periods prior are prepared on a pro forma basis. Results for the second quarter of 2019 and
subsequent periods are prepared on an as-reported basis.
Pro Forma 2019 Net Sales
1
Pro Forma 2019 Net Sales
1 
Pro Forma 2019 Net Sales
1

-- 18 of 40 --



-- 19 of 40 --



-- 20 of 40 --

Net Sales by Business
21
PACKAGING & S PECIALTY PLASTICS
Financial Performance Snapshot
In millions, except margin percentages
1Q20
As Reported
1Q19
Pro Forma
B/(W)
Net Sales 	$4,609 	$5,138 	$(529) 	(10)%
Op. EBIT 	$580 	$690 	$(110) 	(16)%
Op. EBIT Margin 	12.6% 	13.4% 	(80) bps
Adj. Op. EBIT (ex. Eq. Earn.) 	$575 	$652 	$(77) 	(12)%
Adj. Op. EBIT Margin (ex. Eq. Earn.) 	12.5% 	12.7% 	(20) bps
Hydrocarbons
& Energy
Packaging
and
Specialty
Plastics
EMEAI
APAC	LAA
U.S. &
Canada
Variances vs. SQLY Pro Forma
Sales Local
Price 	FX 	Volume Op.
EBIT
Packaging & Specialty Plastics 	-10% 	-9% 	-1% 	– 	
Packaging and Specialty Plastics 	 	 	 	 	
Hydrocarbons & Energy 	 	 	 	 	
Net Sales by Geographic Region
Strong consumer-led packaging demand growth, more than offset by overall margin compression

-- 21 of 40 --

Net Sales by Business
22
INDUSTRIAL INTERMEDIATES & INFRASTRUCTURE
Financial Performance Snapshot
In millions, except margin percentages
1Q20
As Reported
1Q19
Pro Forma
B/(W)
Net Sales 	$3,045 	$3,489 	$(444) 	(13)%
Op. EBIT 	$175 	$277 	$(102) 	(37)%
Op. EBIT Margin 	5.7% 	7.9% 	(220) bps
Adj. Op. EBIT (ex. Eq. Earn.) 	$251 	$325 	$(74) 	(23)%
Adj. Op. EBIT Margin (ex. Eq. Earn.) 	8.2% 	9.3% 	(110) bps
Polyurethanes
& Construction
Chemicals
Industrial
Solutions
EMEAI
APAC
LAA
U.S. &
Canada
Variances vs. SQLY Pro Forma
Sales Local
Price 	FX 	Volume Op.
EBIT
Ind. Intermediates & Infrastructure 	-13% 	-9% 	-1% 	-3% 	
Industrial Solutions 	 	 	 	 	
Polyurethanes & Construction Chem. 	 	 	 	 	
Net Sales by Geographic Region
Demand growth in sanitization materials, more than offset by margin compression & lower equity earnings

-- 22 of 40 --

Net Sales by Business
23
PERFORMANCE M ATERIALS & COATINGS
Financial Performance Snapshot
In millions, except margin percentages
1Q20
As Reported
1Q19
Pro Forma
B/(W)
Net Sales 	$2,065 	$2,320 	$(255) 	(11)%
Op. EBIT 	$162 	$271 	$(109) 	(40)%
Op. EBIT Margin 	7.8% 	11.7% 	(390) bps
Coatings &
Perf.
Monomers
Consumer
Solutions
EMEAI
APAC
LAA
U.S. &
Canada
Variances vs. SQLY Pro Forma
Sales Local
Price 	FX 	Volume Op.
EBIT
Performance Materials & Coatings 	-11% 	-7% 	-1% 	-3% 	
Consumer Solutions 	 	 	 	 	
Coatings & Perf. Monomers 	 	 	 	 	
Net Sales by Geographic Region
Demand growth in industrial coatings and monomers, more than offset by margin compression in siloxanes

-- 23 of 40 --

24
PRINCIPAL JOINT VENTURE DETAIL
1Q 2020 	1Q 2019
$ millions (unaudited) Sadara
Kuwait
JVs
Thai
JVs 	Sadara
Kuwait
JVs
Thai
JVs
EBITDA 	$9 	$110 	$4 	$28 	$128 	$34
EBIT 	$(78) 	$65 	$(6) 	$(58) 	$93 	$24
Net Income
Equity Earnings (Losses) to Dow $(116) 	$40 	$(9) 	$(120) 	$81 	$21
EBITDA in Excess of Eq. Earnings 	$125 	$70 	$13 	$148 	$47 	$13
Net Debt 	$4,611 	$1,753 	$290 	$4,593 	$1,955 	$337
Dow’s Proportionate Share of Principal JV Financial Results
 Kuwait JVs: Margin compression
in MEG and polyethylene
 Thai JVs: Polyethylene margin
compression and styrene
monomer declines, attributable
in part to turnaround activity
 Sadara: Margin compression in
isocyanates and polyethylene
Drivers of YoY Changes

-- 24 of 40 --

FY19 BENCHMARKING UPDATE

-- 25 of 40 --

26
C ULTURE OF BENCHMARKING : S UMMARY OF OBSERVATIONS
Segment 	FY19 Benchmarking: Strengths & Gaps
P&SP
 FY19 YoY Adj. Op. EBITDA decline significantly less than peers
 Adj. Op. EBITDA per pound polyolefin capacity ahead of peers; advantage widened
 Adj. Op. EBITDA margin was among highest in the peer group
 Free Cash Conversion improved and scored among highest in the peer group
 SG&A + R&D as % of sales remained among lowest in the peer group
II&I
 FY19 YoY Adj. Op. EBITDA decline less than median, driven by lower merchant isocyanates exposure and
continued PU Systems growth
 Adj. Op. EBITDA margin below peer median, but gap narrowed due to cost synergies and stranded cost removal
 Free Cash Conversion remained among highest in the peer group
 SG&A + R&D as % of sales remained among lowest in the peer group
PM&C
 FY19 YoY Adj. Op. EBITDA growth lagged peers, driven by greater exposure to merchant siloxanes
 Adj. Op. EBITDA margin remained better than peer median; gap to best-in-class
 Free Cash Conversion among highest in the peer group
 SG&A + R&D as % of sales best-in-class; expanded advantage vs. next closest peer
Source: Dow on a pro forma basis, CapitalIQ.
Adjusted Operating EBITDA is defined as Operating EBITDA, excluding equity earnings. Dow data for Pro Forma Adj. Op.
EBITDA Growth and Pro Forma Adj. Op. EBITDA Margin are based on Dow operating segment financial results.
Pro Forma Free Cash Conversion for Dow is defined as Pro Forma Adj. Op. EBITDA, less Capex, divided by
Pro Forma Adj. Op. EBITDA. Reconciliation contained at the end of this presentation.
SG&A and R&D metrics based on Pro Forma financials.

-- 26 of 40 --

27
BENCHMARKING PEERS – CONSISTENT WITH INVESTOR DAY 2018
PM&C (1)
II&I
P&SP
Intermediates & Derivatives
Silicones
Corporate
Corporate
Corporate
Corporate
Coatings,
Adhesives,
Specialties
Ind Sp. and Acetyl
Benchmarking conducted against segment level peers if sufficient information disclosed, otherwise corporate level
Silicones
Olefins & Polyolefins Polyolefins	Chemicals 	Corporate
(1) Momentive was acquired by KCC and no longer provides publicly available data; therefore, it has been
excluded from the peer set for the PM&C segment.

-- 27 of 40 --

28
PACKAGING & S PECIALTY PLASTICS
(1) Adjusted Operating EBITDA is defined as Operating EBITDA, excluding equity earnings. Dow data for Pro Forma Adj. Op. EBITDA
Growth and Pro Forma Adj. Op. EBITDA Margin are based on Dow operating segment financial results.
(2) Benchmarking peer set range includes: LyondellBasell Olefins & Polyolefins, Chevron Phillip Chemical, Borealis Polyolefins,
ExxonMobil Chemicals (entire segment).
Adj. Op. EBITDA
Growth (TTM)
Adj. Op. EBITDA
Margin (TTM)
Free Cash Conversion
(FY)
SG&A + R&D
(FY, as a % of Sales)
• World-class packaging
franchise
• Most flexible feedstock
capability in the industry
• Flexible polyolefins
assets
• Proprietary catalyst and
process technology
• Differentiated co-
monomer capability
• Global, low-cost
footprint
• Complete stranded
cost removal, capture
further productivity
gains
• Maintain and enhance
cash conversion
• Pursue incremental,
forward-integration
investments
• Re-allocate resources
to ensure highest
return to ethylene
• Energy intensity, CO2
footprint, improved
yield	-60%
-40%
-20%
0%
5%
10%
15%
20%
25%
-20%
0%
20%
40%
60%
80%
0%
5%
10%
15%
Median
Excl. Dow
CORE STRENGTHS 	FOCUS AREAS
FY19 vs.
FY18
Investor
Day 2018 	FY19 	FY19 	FY19
Median
Excl. Dow
Median
Excl. Dow
Median
Excl. Dow
Median
Excl. Dow
Median
Excl. Dow	Median
Excl. Dow
Median
Excl. Dow
(3) Pro Forma Free Cash Conversion for Dow is defined as Pro Forma Adj. Op. EBITDA, less Capex,
divided by Pro Forma Adj. Op. EBITDA.
(4) SG&A and R&D metrics based on Pro Forma financials.
(5) Median excludes Dow.
(6) Borealis results are as of 2Q19 TTM per company filed interim financial report.
BENCHMARKING SNAPSHOT on a Pro Forma Basis (1,2,3,4,5,6)
FY19 UPDATE & INVESTOR DAY 2018
Investor
Day 2018
Investor
Day 2018
Investor
Day 2018
Investor Day 2018 Reflects: 2Q18 TTM vs. 2Q17 TTM for Op. EBITDA Growth; 2Q18 TTM Op. EBITDA Margin, and FY17 for Free
Cash Conversion and SG&A + R&D (FY, as a % of Sales).
For further unaudited pro forma financial information, refer to the Company’s Current Report on Form 8-K dated
June 3, 2019 and 4Q19 Earnings materials included in the Current Report on Form 8-K dated January 29, 2020.
Source: Dow on a pro forma basis, CapitalIQ.

-- 28 of 40 --

• Full feedstock-to-polymer integration
delivers enhanced value
• Differentiated portfolio delivers margin
resiliency
• 	Functional Polymers portfolio dampens trends
• 	Leading market & application participation
• Additional benefits from:
• 	Uniquely advantaged feedstock cost positions
• 	Superior upstream cracker flexibility
29
R ETURN ON POLYOLEFIN C APACITY
Source: Dow on a pro forma basis, Peer company reported capacities, ICIS.
19
14
4
22
21
12
Lyondell O&P	Dow P&SP 	Borealis Polyolefins2
Op. EBITDA Per Pound
Polyolefins Capacity1 (cpp)
(1) Segment EBITDA based on FY19 reported figures including equity income from affiliates/JVs (Borealis based on 2Q19 TTM with FY18
D&A). Capacity based on latest company reported nameplate for PE and PP (2019 for Dow, 2019 Data book source for Lyondell) including
share of JVs, or ICIS reported capacity for 2019 including share of JVs if not available (Borealis).
(2) Borealis Polyolefins EBITDA adjusted for equity earnings from JVs.
FY19 Investor
Day 2018
Dow’s P&SP Returns
Remain Ahead of Peers
FY19 Investor
Day 2018 FY19 Investor
Day 2018
Investor Day 2018 Reflects 2Q18 TTM.

-- 29 of 40 --

30
INDUSTRIAL INTERMEDIATES & INFRASTRUCTURE
(1) Adjusted Operating EBITDA is defined as Operating EBITDA, excluding equity earnings. Dow data for Pro Forma Adj. Op. EBITDA
Growth and Pro Forma Adj. Op. EBITDA Margin are based on Dow operating segment financial results.
(2) Benchmarking peer set range includes: Eastman, Huntsman, Covestro, LyondellBasell Intermediates & Derivatives segment.
BENCHMARKING SNAPSHOT on a Pro Forma Basis (1,2,3,4,5)
FY19 UPDATE & INVESTOR DAY 2018
• Top global producer of
key raw materials (EO,
PO)
• Flexible manufacturing
model
• Incremental asset
expansions
• Top 3 PU Systems
House business
• Industrial Solutions
contains products with
some of the highest
returns to ethylene
• Complete stranded
cost removal,
capture further
productivity gains
• Shift PU mix to Perf.
Polyols & Systems
• Tilt Industrial
Solutions mix toward
highest returns to
ethylene
• Implement
incremental
expansions (glycol
ethers, alkoxylates)
FOCUS AREAS
(3) Pro Forma Free Cash Conversion for Dow is defined as Pro Forma Adj. Op. EBITDA, less Capex,
divided by Pro Forma Adj. Op. EBITDA.
(4) SG&A and R&D metrics based on Pro Forma financials.
(5) Median excludes Dow.
Adj. Op. EBITDA
Growth (TTM)
Adj. Op. EBITDA
Margin 	(TTM)
Free Cash Conversion
(FY)
SG&A + R&D
(FY, as a % of Sales)
-60%
-40%
-20%
0%
20%
40%
60%
10%
15%
20%
25%
30%
50%
70%
90%
0%
5%
10%
15%
Median
Excl. Dow
Median
Excl. Dow
Median
Excl. Dow
Median
Excl. Dow
Median
Excl. Dow
Median
Excl. Dow 	Median
Excl. Dow
Median
Excl. Dow
CORE STRENGTHS
FY19 vs.
FY18
Investor
Day 2018 	FY19 	FY19 	FY19
Investor
Day 2018
Investor
Day 2018
Investor
Day 2018
Investor Day 2018 Reflects: 2Q18 TTM vs. 2Q17 TTM for Op. EBITDA Growth; 2Q18 TTM Op. EBITDA Margin, and FY17 for Free
Cash Conversion and SG&A + R&D (FY, as a % of Sales).
For further unaudited pro forma financial information, refer to the Company’s Current Report on Form 8-K dated
June 3, 2019 and 4Q19 Earnings materials included in the Current Report on Form 8-K dated January 29, 2020.
Source: Dow on a pro forma basis, CapitalIQ.

-- 30 of 40 --

31
PERFORMANCE M ATERIALS & COATINGS
(1) Adjusted Operating EBITDA is defined as Operating EBITDA, excluding equity earnings. Dow data for Pro Forma Adj. Op. EBITDA
Growth and Pro Forma Adj. Op. EBITDA Margin are based on Dow operating segment financial results.
(2) Benchmarking peer set range includes: Celanese Acetyl Chain, Wacker Silicones segment, Shin-Etsu Silicones segment, Arkema,
Covestro Coatings segment.
Adj. Op. EBITDA
Growth (TTM)
Adj. Op. EBITDA
Margin (TTM)
SG&A + R&D
(FY, as a % of Sales)
(3) Pro Forma Free Cash Conversion for Dow is defined as Pro Forma Adj. Op. EBITDA, less Capex,
divided by Pro Forma Adj. Op. EBITDA.
(4) SG&A and R&D metrics based on Pro Forma financials.
(5) Median excludes Dow.
(6) Wacker and Arkema results for SG&A + R&D are as of 3Q19 TTM; All other results are as of FY19.
FOCUS AREAS
• Complete stranded
cost removal and
further productivity
gains
• Pursue incremental
silicones expansions
• Deliver hybrid
chemistry solutions
• Improve acrylics
margins, drive more
captive use
• Implement B2B digital
model for coatings
• Increase industrial
coatings portfolio
• World-class
silicones franchise
• Lowest cost
siloxanes producer
• Leading coatings
solutions provider
• World-scale acrylic
monomer assets
• One of the largest
B2B digital platforms
• Unique hybrid
chemistry opportunities
• Leading SG&A and
R&D efficiency
Source: Dow on a pro forma basis, CapitalIQ.
-35%
-15%
5%
25%
45%
65%
85%
10%
15%
20%
25%
30%
35%
45%
55%
65%
75%
85%
5%
10%
15%
20%
Free Cash Conversion
(FY)
Median
Excl. Dow
Median
Excl. Dow
Median
Excl. Dow
Median
Excl. Dow
Median
Excl. Dow
Median
Excl. Dow
Median
Excl. Dow	
Median
Excl. Dow
BENCHMARKING SNAPSHOT on a Pro Forma Basis (1,2,3,4,5,6)
FY19 UPDATE & INVESTOR DAY 2018
CORE STRENGTHS
FY19 vs.
FY18
Investor
Day 2018 	FY19 	FY19 	FY19
Investor
Day 2018
Investor
Day 2018
Investor
Day 2018
Investor Day 2018 Reflects: 2Q18 TTM vs. 2Q17 TTM for Op. EBITDA Growth; 2Q18 TTM Op. EBITDA Margin, and FY17 for
Free Cash Conversion and SG&A + R&D (FY, as a % of Sales)
For further unaudited pro forma financial information, refer to the Company’s Current Report on Form 8-K dated
June 3, 2019 and 4Q19 Earnings materials included in the Current Report on Form 8-K dated January 29, 2020.

-- 31 of 40 --

APPENDIX

-- 32 of 40 --

33
GENERAL COMMENTS
Separation from DowDuPont
On April 1, 2019, DowDuPont Inc. ("DowDuPont" and effective June 3, 2019, n/k/a DuPont de Nemours, Inc. or "DuPont") completed the separation of its materials science business and Dow Inc. became the direct parent company of
The Dow Chemical Company and its consolidated subsidiaries ("TDCC" and together with Dow Inc., "Dow" or the "Company"), owning all of the outstanding common shares of TDCC. For filings related to the period commencing April
1, 2019 and thereafter, TDCC was deemed the predecessor to Dow Inc., and the historical results of TDCC are deemed the historical results of Dow Inc. for periods prior to and including March 31, 2019. The information in this report
reflects the results of Dow and its consolidated subsidiaries, after giving effect to the distribution to DowDuPont of TDCC’s agricultural sciences business (“AgCo”) and specialty products business (“SpecCo”) and the receipt of E. I. du
Pont de Nemours and Company and its consolidated subsidiaries' (“Historical DuPont”) ethylene and ethylene copolymers business (other than its ethylene acrylic elastomers business) ("ECP"). The separation was contemplated by
the merger of equals transaction effective August 31, 2017, under the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017. TDCC and Historical DuPont each merged with subsidiaries of
DowDuPont and, as a result, TDCC and Historical DuPont became subsidiaries of DowDuPont (the “Merger”). Subsequent to the Merger, TDCC and Historical DuPont engaged in a series of internal reorganization and realignment
steps to realign their businesses into three subgroups: agriculture, materials science and specialty products. Dow Inc. was formed as a wholly owned subsidiary of DowDuPont to serve as the holding company for the materials science
business.
Unaudited Pro Forma Financial Information
In order to provide the most meaningful comparison of results of operations and results by segment, supplemental unaudited pro forma financial information has been included in the following financial schedules. The unaudited pro
forma financial information is based on the consolidated financial statements of TDCC, adjusted to give effect to the separation from DowDuPont as if it had been consummated on January 1, 2017. For the three months ended
March 31, 2019, pro forma adjustments have been made for (1) the margin impact of various manufacturing, supply and service related agreements entered into with DuPont and Corteva in connection with the separation which
provide for different pricing than the historical intercompany and intracompany pricing practices of TDCC and Historical DuPont, and (2) the elimination of the impact of events directly attributable to the Merger, internal
reorganization and business realignment, separation, distribution and other related transactions (e.g., one-time transaction costs). The results for the three months ended March 31, 2020, are presented under accounting principles
generally accepted in the United States of America ("U.S. GAAP").
The unaudited pro forma financial information has been presented for informational purposes only and is not necessarily indicative of what Dow's results of operations actually would have been had the separation from DowDuPont
been completed as of January 1, 2017, nor is it indicative of the future operating results of Dow. The unaudited pro forma information does not reflect restructuring or integration activities or other costs following the separation
from DowDuPont that may be incurred to achieve cost or growth synergies of Dow. For further information on the unaudited pro forma financial information, please refer to the Company's Current Report on Form 8-K dated June 3,
2019.
General Comments
Unless otherwise specified, all financial measures in this presentation, where applicable, exclude significant items.

-- 33 of 40 --

34
SAFE HARBOR
Cautionary Statement about Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as
amended. In this context, forward-looking statements often address expected future business and financial performance, financial condition, and other matters, and often contain words such as “anticipate,” “believe,” “estimate,”
“expect,” “intend,” “may,” “opportunity,” “outlook,” “plan,” “project,” “seek,” “should,” “strategy,” “target,” “will,” “will be,” “will continue,” “will likely result,” “would” and similar expressions, and variations or negatives of these words.
Forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties which may cause actual results to differ materially from the forward-looking statements.
Forward-looking statements include, but are not limited to, expectations as to future sales of Dow’s products; the ability to protect Dow’s intellectual property in the United States and abroad; estimates regarding Dow’s capital
requirements and need for and availability of financing; estimates of Dow’s expenses, future revenues and profitability; estimates of the size of the markets for Dow’s products and services and Dow’s ability to compete in such markets;
expectations related to the rate and degree of market acceptance of Dow’s products; the outcome of certain Dow contingencies, such as litigation and environmental matters; estimates of the success of competing technologies that may
become available, the actual and potential impacts of the coronavirus disease 2019 (“COVID-19”) pandemic and the recent excess oil supply and related drop in oil prices and expectations regarding the benefits and costs associated with
each of the foregoing.
Forward-looking statements by their nature address matters that are, to different degrees, uncertain. Forward-looking statements are based on certain assumptions and expectations of future events which may not be realized and speak
only as of the date the statements were made. In addition, forward-looking statements also involve risks, uncertainties and other factors that are beyond Dow’s control that could cause Dow’s actual results to differ materially from those
projected, anticipated or implied in the forward-looking statements. These factors include, but are not limited to: fluctuations in energy and raw material prices; failure to develop and market new products and optimally manage product
life cycles; significant litigation and environmental matters; failure to appropriately manage process safety and product stewardship issues; changes in laws and regulations or political conditions; global economic and capital markets
conditions, such as inflation, market uncertainty, interest and currency exchange rates, and equity and commodity prices; business or supply disruptions; security threats, such as acts of sabotage, terrorism or war; weather events and
natural disasters; ability to protect, defend and enforce Dow’s intellectual property rights; increased competition; changes in relationships with Dow’s significant customers and suppliers; unanticipated expenses such as litigation or legal
settlement expenses; unanticipated business disruptions; Dow’s ability to predict, identify and interpret changes in consumer preferences and demand; Dow’s ability to complete proposed divestitures or acquisitions; Dow’s ability to
realize the expected benefits of acquisitions if they are completed; the availability of financing to Dow in the future and the terms and conditions of such financing; disruptions in Dow’s information technology networks and systems and
risks related to the actual and potential impacts of the COVID-19 pandemic and the recent excess oil supply and related drop in oil prices. Additionally, there may be other risks and uncertainties that Dow is unable to identify at this time
or that Dow does not currently expect to have a material impact on its business.
Risks related to achieving the anticipated benefits of Dow's separation from DowDuPont include, but are not limited to, a number of conditions outside the control of Dow, including risks related to: (i) Dow's inability to achieve some or all
of the benefits that it expects to receive from the separation from DowDuPont; (ii) certain tax risks associated with the separation; (iii) the failure of Dow's pro forma financial information to be a reliable indicator of Dow's future results;
(iv) Dow's inability to receive third-party consents required under the separation agreement; (v) non-compete restrictions under the separation agreement; (vi) receipt of less favorable terms in the commercial agreements Dow entered
into with DuPont and Corteva, Inc. ("Corteva"), including restrictions under intellectual property cross-license agreements, than Dow would have received from an unaffiliated third party; and (vii) Dow's obligation to indemnify DuPont
and/or Corteva for certain liabilities.
Where, in any forward-looking statement, an expectation or belief as to future results or events is expressed, such expectation or belief is based on the current plans and expectations of management and expressed in good faith and
believed to have a reasonable basis, but there can be no assurance that the expectation or belief will result or be achieved or accomplished. For a more detailed discussion of Dow’s risks and uncertainties, see Part I, Item 1A of the Dow
Inc. and TDCC combined Annual Report on Form 10-K for the year ended December 31 2019. Dow Inc. and TDCC assume no obligation to update or revise publicly any forward-looking statements whether because of new information,
future events or otherwise, except as required by securities and other applicable laws.

-- 34 of 40 --

35
N ON-GAAP & DEFINITIONS
Non-GAAP Financial Measures
This presentation includes information that does not conform to U.S. GAAP and are considered non-GAAP measures. These measures include the Company's pro forma consolidated results and pro forma earnings per share on an
adjusted basis. Management uses these measures internally for planning, forecasting and evaluating the performance of the Company's segments, including allocating resources. Dow's management believes that these non-GAAP
measures best reflect the ongoing performance of the Company during the periods presented and provide more relevant and meaningful information to investors as they provide insight with respect to ongoing operating results
of the Company and a more useful comparison of year-over-year results. These non-GAAP measures supplement the Company's U.S. GAAP disclosures and should not be viewed as alternatives to U.S. GAAP measures of
performance. Furthermore, such non-GAAP measures may not be consistent with similar measures provided or used by other companies. Dow does not provide forward-looking U.S. GAAP financial measures or a reconciliation of
forward-looking non-GAAP financial measures to the most comparable U.S. GAAP financial measures on a forward-looking basis because the Company is unable to predict with reasonable certainty the ultimate outcome of
pending litigation, unusual gains and losses, foreign currency exchange gains or losses and potential future asset impairments, as well as discrete taxable events, without unreasonable effort. These items are uncertain, depend on
various factors, and could have a material impact on U.S. GAAP results for the guidance period.
Trademarks
The Dow Diamond, logo and all products, unless otherwise noted, denoted with ™, ℠ or ® are trademarks, service marks or registered trademarks of The Dow Chemical Company or its respective subsidiaries or affiliates. Solely for
convenience, the trademarks, service marks and trade names referred to in this communication may appear without the ™, ℠ or ® symbols, but such references are not intended to indicate, in any way, that we will not assert, to
the fullest extent under applicable law, our rights or the right of the applicable licensor to these trademarks, service marks and trade names. This presentation may also contain trademarks, service marks and trade names of
certain third parties, which are the property of their respective owners. Our use or display of third parties’ trademarks, service marks, trade names or products in this communication is not intended to, and should not be read to,
imply a relationship with or endorsement or sponsorship of us.
Definitions
Pro Forma Operating EBIT is defined as pro forma earnings (i.e., pro forma “income from continuing operations before income taxes”) before interest, excluding the impact of significant items.
Pro forma Operating EBITDA is defined as pro forma earnings (i.e., pro forma “income from continuing operations before income taxes”) before interest, depreciation and amortization, excluding the impact of significant items.
Pro forma Operating EBIT Margin is defined as pro forma Operating EBIT divided by pro forma Net Sales.
Adjusted Pro Forma Operating EBIT is defined as Pro forma Operating EBIT less Equity Earnings.
Adjusted Pro Forma Operating EBIT Margin is defined as Pro Forma Operating EBIT less equity earnings divided by Pro Forma net sales.
Pro forma operating earnings per share is defined as “Pro Forma earnings per common share from continuing operations – diluted” excluding the after-tax impact of significant items.
Operating EBIT is defined as earnings (i.e. “Income from continuing operations before taxes”) before interest, excluding the impact of significant items.
Operating EBITDA is defined as earnings (i.e. “Income from continuing operations before taxes”) before interest, depreciation and amortization, excluding the impact of significant items.
Operating EBIT Margin is defined as Operating EBIT, divided by Net Sales.
Adj. Op. EBIT is defined as Operating EBIT less Equity Earnings.
Adj. Op. EBIT Margin is defined as Operating EBIT less Equity Earnings divided by Net Sales.
Operating EPS - Operating earnings per share is defined as "Earnings per common share from continuing operations - diluted" excluding the after-tax impact of significant items.
Operational Tax Rate is defined as the effective tax rate (i.e., GAAP “Provision for income taxes” dividend by “Income from continuing operations before income taxes”) excluding the impact of significant items.
Free cash flow (FCF) is defined as “Cash flows from Operating Activities - Continuing Operations”, less capital expenditures. Under this definition, free cash flow represents the cash generated by the Company from operations after investing in its
asset base. Free cash flow, combined with cash balances and other sources of liquidity, represent the cash available to fund obligations and provide returns to shareholders. Free cash flow is an integral financial measure used in the Company's
financial planning process.
Cash Flow Conversion is defined as “Cash Flow from Operating Activities – Continuing Operations” divided by Operating EBITDA or Pro Forma Operating EBITDA. Management believes cash flow conversion is an important financial metric as it helps
the Company determine how efficiently it is converting its earnings to cash flow.
Net Debt (JVs) is defined as Long-Term Debt plus Current Portion of Long-Term Debt less Cash and Cash Equivalents.
Kuwait Joint Ventures (JVs) refers to EQUATE Petrochemical Company K.S.C.C., The Kuwait Olefins Company K.S.C.C., and The Kuwait Styrene Company K.S.C.C.
Thai Joint Ventures (JVs) refers to Map Ta Phut Olefins Company Limited and The SCG-Dow Group (Siam Polyethylene Company Limited, Siam Polystyrene Company Limited, Siam Styrene Monomer Co., Ltd., Siam Synthetic Latex Company Limited).

-- 35 of 40 --

OPERATING AND PRO FORMA EPS R ECONCILIATION
36
Significant Items Impacting Results for the Three Months Ended Mar 31, 2020
In millions, except per share amounts (Unaudited) 	Pretax 1 	Net Income 2 	EPS 3
Reported results 	396	$ 	239	$ 	0.32	$
Less: Significant items
Integration and separation costs 	(65) 	(51) 	(0.07)
Restructuring and asset related charges - net 	(96) 	(79) 	(0.11)
Loss on early extinguishment of debt 	(86) 	(70) 	(0.09)
Total significant items 	(247)	$ 	(200)	$ 	(0.27)	$
Operating results (non-GAAP) 	643	$ 	439	$ 	0.59	$
Significant Items Impacting Results for the Three Months Ended Mar 31, 2019
In millions, except per share amounts (Unaudited) 	Pretax 1 	Net Income 2 	EPS 3
Pro forma results 	364	$ 	176	$ 	0.24	$
Less: Significant items
Integration and separation costs 	(402) 	(326) 	(0.44)
Restructuring and asset related charges - net 	(156) 	(150) 	(0.20)
Income tax related items 4 - 	(77) 	(0.10)
Total significant items 	(558)	$ 	(553)	$ 	(0.74)	$
Operating pro forma results (non-GAAP) 	922	$ 	729	$ 	0.98	$
1. "Income from continuing operations before income taxes" or pro forma "Income from continuing operations before income taxes."
2. "Net income available for Dow Inc. common stockholders" or pro forma "Net income available for Dow Inc. common stockholders."
T he income tax effect on significant items was calculated based upon the enacted tax laws and statutory income tax rates applicable in
the tax jurisdiction(s) of the underlying non-GAAP adjustment.
3. "Earnings per common share from continuing operations - diluted" or pro forma "Earnings per common share from continuing
operations - diluted."
4. Related to the preparation for separation and distribution.

-- 36 of 40 --

OPERATING AND PRO FORMA OPERATING EBIT & EBITDA R ECONCILIATION
37
Mar 31, 2019 	Jun 30, 2019 	Sep 30, 2019 	Dec 31, 2019 	Mar 31, 2020
In millions (Unaudited) 	Pro Forma 	As Reported 	As Reported 	As Reported 	As Reported
Income (loss) from continuing operations, net of tax 	221	$ 	90	$ 	347	$ 	(2,310)	$ 	258	$
+ Provision for income taxes on continuing operations 	141 	125 	90 	114 	138
Income (loss) from continuing operations before income taxes 	362	$ 	215	$ 	437	$ 	(2,196)	$ 	396	$
- Interest income 	18 	21 	19 	23 	15
+ Interest expense and amortization of debt discount 	241 	237 	233 	222 	215
- Significant items 	(558) 	(628) 	(466) 	(3,030) 	(247)
Operating EBIT 1 	1,143	$ 	1,059	$ 	1,117	$ 	1,033	$ 	843	$
+ Depreciation and amortization 	743 	743 	739 	713 	724
Operating EBITDA 2 	1,886	$ 	1,802	$ 	1,856	$ 	1,746	$ 	1,567	$
Operating EBITDA - Trailing Twelve Months ("TTM") basis 	7,559	$ 	7,290	$ 	6,971	$
1. Operating EBIT is defined as earnings (i.e., "Income (loss) from continuing operations before income taxes") before interest, excluding the impact of
significant items. Pro forma operating EBIT is defined as pro forma earnings (i.e., "Pro Forma income (loss) from continuing operations before income
taxes") before interest, excluding the impact of significant items.
2. Operating EBIT DA is defined as earnings (i.e., "Income (loss) from continuing operations before income taxes") before interest, depreciation and
amortization, excluding the impact of significant items. Pro forma operating EBIT DA is defined as pro forma earnings (i.e., "Pro Forma income (loss) from
continuing operations before income taxes") before interest, depreciation and amortization, excluding the impact of significant items.
Reconciliation of "Income (loss) from continuing operations,
net of tax" to Operating EBIT and Operating EBITDA
Three Months Ended

-- 37 of 40 --

S EGMENT INFORMATION
38
Net Sales and Pro Forma Net Sales by Segment
Mar 31, 2020 	Mar 31, 2019
In millions (Unaudited) 	As Reported 	Pro Forma
Packaging & Specialty Plastics 	4,609	$ 	5,138	$
Industrial Intermediates & Infrastructure 	3,045 	3,489
Performance M aterials & Coatings 	2,065 	2,320
Corporate 	51 	69
Total net sales by segment 	9,770	$ 	11,016	$
Three Months Ended
Operating and Pro Forma Operating EBIT by Segment
Mar 31, 2020 	Mar 31, 2019
In millions (Unaudited) 	As Reported 	Pro Forma
Packaging & Specialty Plastics 	580	$ 	690	$
Industrial Intermediates & Infrastructure 	175 	277
Performance M aterials & Coatings 	162 	271
Corporate 	(74) 	(95)
Total Operating EBIT by segment 	843	$ 	1,143	$
Three Months Ended
Equity in Earnings (Losses) of Nonconsolidated Affiliates
Mar 31, 2020 	Mar 31, 2019
In millions (Unaudited) 	As Reported 	Pro Forma
Packaging & Specialty Plastics 	5	$ 	38	$
Industrial Intermediates & Infrastructure 	(76) 	(48)
Performance M aterials & Coatings 	1 	-
Corporate 	(19) 	(4)
Total equity in losses of nonconsolidated affiliates by segment 	(89)	$ 	(14)	$
Three Months Ended

-- 38 of 40 --

S EGMENT INFORMATION (CONTINUED )
39
Operating and Pro Forma Operating EBIT Margin
Mar 31, 2020 	Mar 31, 2019
Percent change (Unaudited) 	As Reported 	Pro Forma
Packaging & Specialty Plastics 	12.6% 	13.4%
Industrial Intermediates & Infrastructure 	5.7% 	7.9%
Performance M aterials & Coatings 	7.8% 	11.7%
Total Operating EBIT margin 	8.6% 	10.4%
Three Months Ended
Mar 31, 2020 	Mar 31, 2019
In millions (Unaudited) 	As Reported 	Pro Forma
Packaging & Specialty Plastics 	575	$ 	652	$
Industrial Intermediates & Infrastructure 	251 	325
Performance M aterials & Coatings 	161 	271
Corporate 	(55) 	(91)
Adjusted Operating and Pro Forma Operating EBIT 	932	$ 	1,157	$
Adjusted Operating and Pro Forma Operating EBIT 	Three Months Ended
Mar 31, 2020 	Mar 31, 2019
Percent change (Unaudited) 	As Reported 	Pro Forma
Packaging & Specialty Plastics 	12.5% 	12.7%
Industrial Intermediates & Infrastructure 	8.2% 	9.3%
Performance M aterials & Coatings 	7.8% 	11.7%
Adjusted Operating and Pro Forma Operating EBIT Margin 	9.5% 	10.5%
Adjusted Operating and Pro Forma Operating EBIT Margin 	Three Months Ended

-- 39 of 40 --

C ASH CONVERSION R ECONCILIATION
40
Operating EBITDA to Cash Flow From Operations Conversion
Mar 31, 2020 	Mar 31, 2019
In millions 	As Reported 	Pro Forma
Cash flows from operating activities - continuing operations 	1,236	$ 	1,043	$
Operating EBITDA 	1,567	$ 	1,886	$
Operating EBITDA to cash flow from operations conversion (non-GAAP) 1 	78.9% 	55.3%
Three Months Ended
1. Operating EBIT DA to cash flow from operations conversion is defined as "Cash Flow from Operating Activities - Continuing
Operations" divided by Operating EBIT DA.
Reconciliation of Non-GAAP Cash Flow Measures
Mar 31, 2019 	Jun 30, 2019 	Sep 30, 2019 	Dec 31, 2019 	Mar 31, 2020
In millions 	Pro Forma 	As Reported 	As Reported 	As Reported 	As Reported
Cash provided by operating activities - continuing operations (GAAP) 	1,043	$ 	960	$ 	1,790	$ 	1,920	$ 	1,236	$
Capital expenditures 	(442) 	(470) 	(472) 	(577) 	(395)
Free cash flow (non-GAAP) 1 601	$ 	490	$ 	1,318	$ 	1,343	$ 	841	$
Free cash flow Trailing Twelve Months ("TTM") basis (non-GAAP) 	3,152	$ 	3,752	$ 	3,992	$
1. Free cash flow is defined as cash flows from operating activities - continuing operations, less capital expenditures. Under this definition, free cash flow represents the cash
generated by the Company from operations after investing in its asset base. Free cash flow, combined with cash balances and other sources of liquidity, represent the cash available to
fund obligations and provide returns to shareholders. Free cash flow is an integral financial measure used in the Company's financial planning process.
Three Months Ended

-- 40 of 40 --